XML 60 R5.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Operating expenses:    
Research and development $ 24,903 $ 33,656
General and administrative 12,811 11,330
Total operating expenses 37,714 44,986
Loss from operations (37,714) (44,986)
Other (expense) income    
Change in fair value of warrant liabilities (1,915) (3,886)
Loss on issuance of pre-funded warrants 0 (3,502)
Gain on sale of equipment 0 3
Foreign exchange transaction gain 0 151
Grant income 415 0
Interest income 776 777
Interest expense (1,133) (455)
Total other expense, net (1,857) (6,912)
Provision for income taxes 0 0
Net loss (39,571) (51,898)
Other comprehensive gain:    
Foreign currency translation adjustment 48 22
Comprehensive loss $ (39,523) $ (51,876)
Net loss per common share, basic (in dollars per share) $ (2.58) $ (4.25)
Net loss per common share, diluted (in dollars per share) $ (2.58) $ (4.25)
Weighted average common shares outstanding, basic (in shares) 15,312,751 12,202,996
Weighted average common shares outstanding, diluted (in shares) 15,312,751 12,202,996